Description

39th Annual “Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis, and Immunology

When: October 28 - 31, 2024
Where: online
Website: https://steelelabs.mgh.harvard.edu/tumorcourse

The “39th Annual Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology” course will continue to offer the best in critical analysis of what is currently known about the tumor microenvironment, angiogenesis, metastasis, immunology. This will include chimeric antigen receptor (CAR) T-cell therapies, tumor metabolism, and the role of microbiome. This year, we will include two new lectures on cancer neuroscience and the use of Artificial Intelligence for cancer research. The faculty is internationally recognized. They will present their latest findings from their clinics and laboratories. The goal is to highlight key gaps in present knowledge of cancer and outline future directions for research at the bench, in the clinic, and in drug development.

The course will continue its four-day online webinar-based live lecture format. Learning formats will include didactic lectures, Q&A and group case discussions. The faculty will encourage an open discussion and will provide critical comments on challenges and future opportunities in research in cancer and in the establishment of novel therapy approaches and biomarkers to guide treatment.

The aim of this course remains to analyze and synthesize the most up-to-date findings. Faculty will present valuable information in a systematic and comprehensive framework and critically review the latest techniques. This course is dedicated to helping to improve the clinical translation of this knowledge and competence, leading to improved cancer treatment.